-
MD Anderson Launches Gamma-Delta T-Cell Therapy Study, New Multi-Year Multi-Omics Cancer Resistance Mechanisms Research, More
Clinical Research News | A major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in multiple cancer types; the first one-stop-shop decentralized clinical trial platform bundled with site and trial execution services for the digital therapeutics market; a unique and unparalleled suite of early to late-phase CRO services across Europe, the US, and Asia Pacific; and more.
Jan 26, 2023
-
Follow the Money: PCORI Opens Nine Research Funding Opportunities, Novel Transcriptome-Wide Profiling Research, More
Clinical Research News | Funding for preclinical development and clinical proof-of-concept therapeutic studies, comparative clinical effectiveness research to help patients and other stakeholders make better-informed health choices, clinical decision support expansion for diagnostic and surveillance tools, and more.
Jan 24, 2023
-
Revolutionizing Payment Products is Vital for Increasing Clinical Trial Participant Satisfaction and Diversity
Clinical Research News | Patient-centricity has become a buzzword in clinical trials, but many practical barriers still limit diversity and reduce participant satisfaction. As an industry, our true north should be making it easier to participate in clinical trials for a meaningful impact on patients and significant added value for sponsors.
Jan 20, 2023
-
Retinal Organoid-Derived Neurons to Potentially Cure Degenerative Eye Disease
Clinical Research News | A new study published in the Proceedings of the National Academy of Science demonstrates the potential for lab-grown retinal neurons to reestablish synaptic function and cure neurodegenerative eye disease, according to researchers from the University of Wisconsin–Madison.
Jan 18, 2023
